DRUG STUDY

Medical Diagnosis: Drug induced Hepatitis 2o anti

koch’s medication
Category: I

Indication/contrai Mechanism of Side Nursing

ndication action effects / consideration
Rationale for adverse s
patient effects
Generic conditions eg • Transien • Patient
name: malabsorption sy t education
Vitamin B- diarrhea : Instruct
ndrome; radiation
Complex with • Itching- patient
sickness; malnutr
vitamin C and strict
Brand name: ition or deficiency
urticarci complianc
Vaneular diseases; severe
a e of
tablet infections. taking
• Anaphyl
actic multivita
Classification shock mins and
: • Increase report
Dietary d uric side-
supplement acid effects
levels,
Dosage: increase
1 tablet d urinary
calcium
Frequency:
Two times a
day

Route:
Per Orem

Date
Ordered:
June 16,
2010

Recommende
d dose:
27 years old-
Mild cases &
for
maintenance 1
-2 tab daily
Therapeutic
level:

Indication/contrai Mechanism of Side Nursing

ndication action effects / consideration
Rationale for adverse s
patient effects
Generic Acute and • Severe • Monitor
name: L-ornithine-L- renal laboratory
chronic liver
L-ornithine-L- disease eg, liver aspartate stimulates impairm results
aspartate ammonia
ent such as
cirrhosis, fatty
liver
liver, hepatitis detoxification by
function
Brand name: enhancing urea
test, and
Hepa-Merz synthesis in the urea
sachet cycle. Additionally, it serum
eliminates creatinine
Classification extrahepatic ammonia level
: from the tissues. exceeding 3
Cholelitholyti mg/100 mL
cs & Hepatic
Protectors
• Dissolve
Dosage: content of
1 sachet the
dissolve with sachet
½ glass of with
water plenty of
liquids
Frequency:
Two times a
day

Route:
Per orem

Date
Ordered:
June 26,2010

Recommende
d dose:
27 years old-
1-2 sachets of
Hepa-Merz 1-
2 times daily

Therapeutic
level:

Indication/contrai Mechanism of Side Nursing

ndication action effects / consideration
Rationale for adverse s
patient effects
Generic Treatment • CNS: • Administe
name: Supress hepatic Anxiety, r with
of cholestatic liver
Ursodeoxych synthesis , biliary fatigue, food
disease.
olic acid secretion and depressi intake
Brand name: intestinal on • Be aware
Ursofalk reabsorbing of • CV: of too
cholesterol. chest much
Classification pain, intake of
: hyperten drug,
Cholelitholyti sion, diarrhea
cs & Hepatic peripher may
Protectors al occur
edema. • Urge
Dosage: • Gallston patient to
250 mg/cap e notify the
calcificat physician
Frequency: ion immediat
Three times a ely for
day signs of
acute
Route: cholecytiti
Per orem s

Date
Ordered:
June 16,2010

Recommende
d dose:
27 years old-
300 mg b.i.d.

Therapeutic
level:

Indication/contrai Mechanism of Side Nursing

ndication action effects / consideration
Rationale for adverse s
patient effects
Generic Acute and Chronic • •
name:
Hepatitis. It activates metabolic
function and supports
Brand name: Liver Damaged by
the energy balance of
Essentiale Toxins
the liver. It restores
Forte
enzyme functions and
Classification promotes detoxification
: of the liver. Neutral fats
Cholelitholyti and cholesterol are
cs & Hepatic transformed into
Protectors transportable forms and
led to their physiological
Dosage: oxidation. Liver cell
1 capsule regeneration is
stimulated and the bile
Frequency: is stabilized.
Three times a
day

Route:
Per orem

Date
Ordered:
June 16,2010

Recommende
d dose:
27 years old-
1-2 forte caps 3 times
a day for the
first 2 months

Therapeutic
level:

Indication/contrai
Mechanism of Side Nursing
ndication
action effects / consideration
Rationale for adverse s
patient effects
Generic It makes the • Gi: • Monitor
name: Prevention of intestinal contents Abdomin blood
Lactulose hepatic more acidic than al ammonia
Brand name: encephalopathy blood. This prevent crampin level,
Duphalac ammonia diffusion g and electrolyt
from the intestine distentio es level
Classification into the blood, as n, and signs
: occur in hepatic diarrhea of
Ammonia encephalopathy. and dehydrati
reducer The trapped flatulenc on
ammonia ions and e • Dilute the
Dosage: by lactulose • Hypokal medicatio
30 ml laxative effect is emia, n with
expelled by the hypovole water or
Frequency: feces. mia, take it
Three times a hypernat with food
day remia. • Inform
 patient to
Route: report
Per Orem any
adverse
Date reaction
Ordered: of the
June 16,2010 medicatio
n to the
physician

Recommende
d dose:
27 years old-
20 to 30 g (30
to 45 ml) P.O.
t.i.d. or q.i.d.

Therapeutic
level:

Indication/contrai Mechanism of Side Nursing

ndication action effects / consideration
Rationale for adverse s
patient effects
Generic Acts as the major • Acute • Administe
name: Hypokalemia cation in dehydrat r oral
Potassium intracellular fluid, ion potassium
Chloride activating many • Addison’ with or
Brand name: enzymatic s immediat
Kalium reactions that are disease ely after
essential for • Hyperse meals
Classification physiologic nsitivityt • Mix
: process, including o potassium
Electrolytes nerve impulse potassiu chloride
transmission and m salt for oral
Dosage: cardiac and • Renal solution
skeletal muscle impairm in cold
Frequency: contraction. ent water,
For ever 6 Given to patient orange
• Arrhyth
hours with drugs that mias juice and
causes • Hyperkal stir it for
Route: hypokalemia such emia 1 minute
as lactulose • Rash before
• Ulceratio administe
Date n ring
Ordered: • Nasea • Regularly
June 16,2010 and assess for
vomiting signs of
hypokale
mia
Recommende • Monitor
d dose: for the
27 years old- serum
. creatinine
, and
urinary
outputHe
Therapeutic alth
level: education
: teach
ways on
how to
take
potassium
medicatio
n and
take
drugs
after
meals